1. Home
2. Support

Publications, patents and book chapters citing our work

We provided high-quality service to numerous customers. A long list of papers have been published in Peer-reviewed Publications journals and a lot of patent applications have been approved or in process with custom products or services from us. Below are some selected patents and papers to give you an idea of how our products and custom services have been applied as part of leading edge in life science research in academia and industry. These publications are sorted according to different divisions of our company.

Authorship

1. Maragos, Chris M., Lan Li, and Donghai Chen. "Production and characterization of a single chain variable fragment (scFv) against the mycotoxindeoxynivalenol." Food and Agricultural Immunology 23.1 (2012): 51-67.

Patents

1. Turkson, James. "Drug composition cytotoxic for pancreatic cancer cells." U.S. Patents No. 8.685.941. 1 Apr. 2014.
2. Turkson, James. "Drug composition cytotoxic for pancreatic cancer cells." EP 2370082. May 30, 2012
3. Turkson, James. "Drug composition cytotoxic for pancreatic cancer cells." WO 2010065444. Jun 10, 2010
4. Turkson, James. "Drug composition cytotoxic for pancreatic cancer cells." CA 2745265. Jun 10, 2010
5. Frederick C. S. WANG, Mark H. FOGG. “Neutralizing antibody for epsteinbarr virus associated disease.” WO 2013130565 Sep 6, 2013
6. Thomas Kodadek, Todd DORAN. “Liquid array platform for multiplexed analysis of molecule-protein interactions.” WO 2014138028. Sep 12, 2014
7. Trieu, Vuong, Xiping Liu, and Neil Desai. "Sparc binding antibodies and uses thereof." EP 2563393. Oct 9, 2013
8. Trieu, Vuong, Xiping Liu, and Neil Desai. "Sparc binding antibodies and uses thereof." U.S. Patents Application 13/643,609. Apr 25, 2013
9. Trieu, Vuong, Xiping Liu, and Neil Desai. "Sparc binding antibodies and uses thereof."WO 2011137114. Nov 3, 2011
10. John T. Unger, Rolf Hilfiker. “Conformational epitope initiated signal amplification.” U.S. Patents No. 13.263.367. Feb 16, 2012
11. John T. Unger, Rolf Hilfiker. “Conformational epitope initiated signal amplification.” WO 2010118300. Oct 14, 2010
12. Vuong Trieu, Xiping Liu, Neil Desai. “Peripheral blood SPARC antibodies and uses thereof.” EP2598164. Apr 9, 2014
13. Vuong Trieu, Xiping Liu, Neil Desai. “Peripheral blood SPARC antibodies and uses thereof.” CN 103221062. Jul 24, 2013
14. Vuong Trieu, Xiping Liu, Neil Desai. “Peripheral blood SPARC antibodies and uses thereof.” WO2011153431. Apr 11, 2013
15. Vuong Trieu, Xiping Liu, Neil Desai. “Peripheral blood SPARC antibodies and use
16. s thereof.” U.S. Patents No. 13.152.753. Mar 1, 2012
17. Vuong Trieu, Xiping Liu, Neil Desai. “Peripheral blood sparc binding antibodies and uses thereof.” CA 2801184. Dec 8, 2011
18. Hendrix, Mary Jessica, et al. "Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells." U.S. Patents No. 8,669,239. Mar 11, 2014.
19. Hendrix, Mary Jessica, et al. "Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells."U.S. Patents No. 13,572,273. Mar 11, 2014
20. Hendrix, Mary Jessica, et al. "Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells." EP 2412383. Feb 1, 2012
21. Hendrix, Mary Jessica, et al. "Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells." U.S. Patents No. 8,106,004. Jan 31, 2012.
22. Hendrix, Mary Jessica, et al. "Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells."U.S. Patents No. 12.683.313. Oct 28, 2010
23. Hendrix, Mary Jessica, et al. "Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells." U.S. Patents No. 12,375,443. Apr 29, 2010
24. Hendrix, Mary Jessica, et al. "Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells."U.S. Patents No. 11,829,070. Feb 23, 2010
25. Hendrix, Mary Jessica, et al. "Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells." EP 2074209. Jul 1, 2009
26. Hendrix, Mary Jessica, et al. "Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells." CA 2658786. Jan 31, 2008
27. Hendrix, Mary Jessica, et al. "Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells." WO2008014426. Jan 31, 2008
28. Chenguang Wang, Jie Zhou. “Compositions and methods for treating cancer with aberrant lipogenic signaling.” WO 2014004054. Jan 3, 2014
29. Franco, Alessandra. "Glycopeptides and methods of making and using them." EP2250189. Jul 4, 2012
30. Franco, Alessandra. "Glycopeptides and methods of making and using them." U.S. Patents Application 12,918,155.Feb 24, 2011
31. Franco, Alessandra. "Glycopeptides and methods of making and using them." CA 2716622. Sep 3, 2009
32. Franco, Alessandra. "Glycopeptides and methods of making and using them." WO 2009108807. Sep 3, 2009
33. Stagliano, Nancy E., et al. "Modified antibody compositions, methods of making and using thereof." U.S. Patents No. 14,038,232. Jan 23, 2014
34. Stagliano, Nancy E., et al. "Modified antibody compositions, methods of making and using thereof." U.S. Patents No. 13,784,407. Nov 21, 2013
35. Stagliano, Nancy E., et al. "Modified antibody compositions, methods of making and using thereof." U.S. Patents No. 8,563,269. 22 Oct. 2013
36. Stagliano, Nancy E., et al. "Modified antibody compositions, methods of making and using thereof." U.S. Patents No. 8,513,390. 20 Aug. 2013
37. Stagliano, Nancy E., et al. "Modified antibody compositions, methods of making and using thereof." EP2385955. Feb 13, 2013
38. Stagliano, Nancy E., et al. "Modified antibody compositions, methods of making and using thereof."CN 102482347. May 30, 2012
39. Stagliano, Nancy E., et al. "Modified antibody compositions, methods of making and using thereof."EP 2385955. Nov 16, 2011
40. Stagliano, Nancy E., et al. "Modified antibody compositions, methods of making and using thereof."WO2010081173. Nov 4, 2010
41. Stagliano, Nancy E., et al. "Modified antibody compositions, methods of making and using thereof." U.S. Patents No. 12,686,344. Jul 29, 2010
42. Stagliano, Nancy E., et al. "Modified antibody compositions, methods of making and using thereof."CA2749339. Jul 15, 2010
43. GernotStuhler. Dual antigen-induced bipartite functional complementation. WO 2013104804. Nov 21, 2013
44. Voss, Jeffrey W., and Carolyn A. Cuff. "Anti-tnf and anti-il 17 combination therapy biomarkers for inflammatory disease." U.S. Patents Application 14/160,253. Jul 24, 2014
45. Voss, Jeffrey W., and Carolyn A. Cuff. "Anti-tnf and anti-il 17 combination therapy biomarkers for inflammatory disease."WO 2014113804. Jul 24, 2014
46. Wirostko, Barbara. "Ocular drug delivery system." CN 103619327. Mar 5, 2014
47. Wirostko, Barbara. "Ocular drug delivery system." U.S. Patents Application 13/977,870. Dec 12, 2013
48. Wirostko, Barbara. "Ocular drug delivery system." EP2658529. Nov 6, 2013
49. Wirostko, Barbara. "Ocular drug delivery system." WO2012092510. Nov 1, 2012
50. John Andrew Zupancich. “Process for the manufacturing of a drug delivery system based on a polymer comprising a dispersed bioactive agent.” WO 2013087903. Jun 20, 2013
51. Xu Hun, Guoqing Su. “Method for determining gibberellin based on hybridization chain-reaction signal amplification technology.” CN 103674935. Mar 26, 2014
52. Xiaoju Wang, Guojun Wu, et al. “Liquid chip kit for diagnosing lung cancer.” CN 103389375. Nov 13, 2013
53. Ning Xu, Hangping Yao. “Immunity-chromatography test paper for rapid detection of mycobacterium tuberculosis secretory protein and preparation method thereof.” CN 102426244. Apr 9, 2014.
54. Ning Xu, Hangping Yao. “Double-layer immunochromatography test paper.” CN 202631542. Dec 26, 2012
55. YumeiXiong, Yi Zhang, et al.“Polypeptides du facteur de croissanceet de différenciation 15 (gdf-15).” WO 2013113008. Aug 1, 2013
56. Weiner, Howard, and Oleg Butovsky. "Methods of Treating Inflammatory Diseases by Targeting the Chemoattractant Cytokine Receptor 2 (CCR2) or Chemokine (CC motif) Ligand 2 (CCL2)." U.S. Patents Application 14/110,012. Jun 26, 2014
57. Weiner, Howard, and Oleg Butovsky. "Methods of Treating Inflammatory Diseases by Targeting the Chemoattractant Cytokine Receptor 2 (CCR2) or Chemokine (CC motif) Ligand 2 (CCL2)." WO 2012138880. Oct 11, 2012
58. Lambris, John D., and George Hajishengallis. "Methods of treating or preventing periodontitis and diseases associated with periodontitis." WO 2013192319. Dec 27, 2013
59. Lambris, John D., and George Hajishengallis. "Methods of treating or preventing periodontitis and diseases associated with periodontitis." U.S. Patents Application 13/801,096. Dec 26, 2013
60. Sheng-he HUANG, Ambrose JONG, Feng Chi, Lin Wang. “Circulating bmec and related cells as biomarkers of cns diseases associated with the blood-brain-barrier disorders.” WO 2014124174. Aug 14, 2014
61. Robinson, Matthew K., John K. Cini, and Jimson W. D'souza. "Antibodies that specifically bind to serum albumin without interfering with albumin's capability to interact with the fcrn." U.S. Patents Application 13/826,656. Jul 3, 2014
62. Robinson, Matthew K., John K. Cini, and Jimson W. D'souza. "Antibodies that specifically bind to serum albumin without interfering with albumin's capability to interact with the fcrn." WO 2013025759. Feb 21, 2013
63. Zhang, Qibin, and Thomas O. Metz. "Peptide and protein biomarkers for type 1 diabetes mellitus." U.S. Patents Application 13/586,321. Jun 10, 2014
64. Zhang, Qibin, and Thomas O. Metz. "Peptide and protein biomarkers for type 1 diabetes mellitus." WO 2013025759. Feb 21, 2013
65. Anna L FURMANSKI, Jose Ignacio SALDANA, Tessa Crompton. A negative modulator of hedgehog signalling for use in treating th2 -mediated diseases. WO 2013136086. Sep 19, 2013
66. Tessa Crompton, Ching-In LAU, Susan OUTRAM. Erythropoiesis. WO 2013132272. Sep 12, 2013
67. Keith BONIN, Jed C. Macosko, Jason GAGLIANO, Martin Guthold, Roger Cubicciotti. Integrated compound discovery systems and methods. WO 2013096777. Sep 26, 2013
68. Buelow, Roland, and Wim Van Schooten. "Bispecific three-chain antibody-like molecules." CN 103619876. Mar 5, 2014
69. Buelow, Roland, and Wim Van Schooten. "Bispecific three-chain antibody-like molecules." U.S. Patents Application 14/001,250. Feb 27, 2014
70. Buelow, Roland, and Wim Van Schooten. "Bispecific three-chain antibody-like molecules." EP 2683735. Jan 15, 2014
71. Buelow, Roland, and Wim Van Schooten. "Bispecific three-chain antibody-like molecules." CA2828347. Sep 13, 2012
72. Buelow, Roland, and Wim Van Schooten. "Bispecific three-chain antibody-like molecules."WO2012122528. Sep 13, 2012
73. Thale C. Jarvis, John C. et al. Aptamers to pdgf and vegf and their use in treating pdgf and vegf mediated conditions. WO 2013149086. Oct 3, 2013
74. Eustache Paramithiotis, Marc Prentki, Rèmi RABASA-LHORET. Type 2 diabetes biomarkers and uses thereof. WO 2014118634. Aug 7, 2014
75. GuiyingNie, Harmeet Singh, Kemperly DYNON. Antibodies to htra3. WO 2013149306. Oct 10, 2013
76. Peter Ebbesen, Nina F. Jeppesen EDIN, Erik OlaiPettersen, Joe Alexander SANDVIK. Method of determining wether a subject is resistant to chemotherapy with dna damaging agents. WO 2012117107. Sep 7, 2012
77. Voss, Jeffrey W., and Carolyn A. Cuff. "Anti-tnf and anti-il 17 combination therapy biomarkers for inflammatory disease." WO 2014113804. Jul 24, 2014
78. Voss, Jeffrey W., and Carolyn A. Cuff. "Anti-tnf and anti-il 17 combination therapy biomarkers for inflammatory disease." U.S. Patents Application 14/160,253. Jul 24, 2014
79. Ning Xu, Hangping Yao. Immunity-chromatography test paper for rapid detection of mycobacterium tuberculosis secretory protein and preparation method thereof. CN 102426244. Apr 9, 2014
80. Naro Antonio Francesco Di. Anti-cd26 antibodies and uses thereof. WO 201412816. Aug 28, 2014
81. Koji Nakamura, Kentaro Okamura, et al. “Anti-human trop-2 antibody exhibiting antitumor activity in vivo.” US 13/682,319. Dec 26, 2013
82. Koji Nakamura, Kentaro Okamura, et al. “Anti-human trop-2 antibody exhibiting antitumor activity in vivo.” WO 2013077458. May 30, 2013
83. Koji Nakamura, Kentaro Okamura, et al. “Anti-human trop-2 antibody exhibiting antitumor activity in vivo.” CA 2855699. May 30, 2013
84. Dockal, Michael, et al. "TFPI inhibitors and methods of use." U.S. Patents No. 13/846,359. Oct 3, 2013
85. Dockal, Michael, et al. "TFPI inhibitors and methods of use." WO2011115712. Oct 10, 2013
86. Dockal, Michael, et al. "Tfpi inhibitors and methods of use." U.S. Patents Application 13/756,036. Sep 26, 2013
87. Dockal, Michael, et al. "Tfpi inhibitors and methods of use." WO 2013141965, Sep 26, 2013
88. Dockal, Michael, et al. "TFPI inhibitors and methods of use."EP2547355. Sep 11, 2013
89. Dockal, Michael, et al. "TFPI inhibitors and methods of use."CN103025345. Apr 3, 2013
90. Dockal, Michael, et al. "TFPI inhibitors and methods of use." U.S. Patents No. 8,450,275. 28 May 2013.
91. Dockal, Michael, et al. "TFPI inhibitors and methods of use." CA 2793465. Sep 22, 2011
92. David HALBERT, Valeriy DOMENYUK, David Spetzler, Tassilo HORNUNG, Frank Schafer, Nick XIAO. Aptamers and uses thereof. WO 2014068408. May 8, 2014

Peer-reviewed Publications

1. Timoshevskaya I. Single-Molecule Fluorescence Studies of Glycosylated and AglycosylatedAntibodies[J]. DePaul Discoveries, 2014, 1(1): 11.
2. Kelliher, Michael T., et al. "The effect of sugar removal on the structure of the Fc region of an IgG antibody as observed with single molecule Förster Resonance Energy Transfer." Molecular immunology 60.2 (2014): 103-108.
3. Kim, Mi‐Sun, et al. "Comparative study of various growth factors and cytokines on type I collagen and hyaluronan production in human dermal fibroblasts." Journal of cosmetic dermatology 13.1 (2014): 44-51.
4. Lopez-Rivera, Esther, et al. "Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2." Cancer research 74.4 (2014): 1067-1078.
5. Tay, Moon YF, et al. "Identification of Dengue-Specific Human Antibody Fragments Using Phage Display." Dengue. Springer New York, 2014. 161-173.
6. Wang, Yun, et al. "Developing an Irreversible Inhibitor of Human DDAH‐1, an Enzyme Upregulated in Melanoma." ChemMedChem 9.4 (2014): 792-797.
7. Doran, Todd M., and Thomas Kodadek. "A Liquid Array Platform for the Multiplexed Analysis of Synthetic Molecule–Protein Interactions." ACS chemical biology 9.2 (2013): 339-346.
8. Wu, Yongzhong, et al. "Activation of TLR4 is required for the synergistic induction of dual oxidase 2 and dual oxidase A2 by IFN-γ and lipopolysaccharide in human pancreatic cancer cell lines." The Journal of Immunology 190.4 (2013): 1859-1872.
9. Mallavia, Beñat, et al. "Peptide Inhibitor of Nuclear Factor-kB Translocation Ameliorates Experimental Atherosclerosis." The American Journal of Pathology182.5 (2013).
10. Cheng, Yong, Niamh X. Cawley, and Y. Peng Loh. "Carboxypeptidase E/NFα1: A new neurotrophic factor against oxidative stress-induced apoptotic cell death mediated by ERK and PI3-K/AKT pathways." PloS one 8.8 (2013): e71578.
11. Borges, Sahra, et al. "Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis." Breast Cancer Res 15 (2013): R66.
12. Pei, Zhengtong, et al. "Very Long-Chain Acyl-CoA Synthetase 3: Overexpression and Growth Dependence in Lung Cancer." PloS one 8.7 (2013): e69392.
13. Mallavia, Beñat, et al. "Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis." The American journal of pathology 182.5 (2013): 1910-1921.
14. Woods, Alisa G., et al. "Identification of tumor differentiation factor (TDF) in select CNS neurons." Brain Structure and Function (2013): 1-10.
15. Antony, Smitha, et al. "Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody."Free Radical Biology and Medicine 65 (2013): 497-508.
16. Sokolowska I, Woods A G, Gawinowicz M A, et al. Identification of potential tumor differentiation factor (TDF) receptor from steroid-responsive and steroid-resistant breast cancer cells[J]. Journal of Biological Chemistry, 2012, 287(3): 1719-1733.
17. Wang X, Wang S, Lu Y, et al. FAM20C plays an essential role in the formation of murine teeth[J]. Journal of Biological Chemistry, 2012, 287(43): 35934-35942.
18. Fukunaga, Keisuke, and Masumi Taki. "Practical tips for construction of custom peptide libraries and affinity selection by using commercially available phage display cloning systems." Journal of nucleic acids 2012 (2012).
19. Roy, Urmi, et al. "Structural investigation of tumor differentiation factor."Biotechnology and applied biochemistry 59.6 (2012): 445-450.
20. Parra, Gabriel I., et al. "Multiple antigenic sites are involved in blocking the interaction of GII. 4 norovirus capsid with ABH histo-blood group antigens."Journal of virology 86.13 (2012): 7414-7426.
21. Lee, Cheol, et al. "The molecular profiles of neural stem cell niche in the adult subventricular zone." PloS one 7.11 (2012): e50501.
22. Telikicherla, Deepthi, et al. "Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer." Clinical proteomics 9.1 (2012): 7.
23. Bao, Xiaofeng, et al. "Non-coding nucleotides and amino acids near the active site regulate peptide deformylase expression and inhibitor susceptibility in Chlamydia trachomatis." Microbiology 157.9 (2011): 2569-2581.
24. Torres, Lorena, et al. "Functional genomics of the horn fly, Haematobiairritans (Linnaeus, 1758)." BMC genomics 12.1 (2011): 105.
25. Wu, Yongzhong, et al. "Up-regulation and sustained activation of Stat1 are essential for interferon-γ (IFN-γ)-induced dual oxidase 2 (Duox2) and dual oxidase A2 (DuoxA2) expression in human pancreatic cancer cell lines."Journal of Biological Chemistry 286.14 (2011): 12245-12256.
26. Jia, Lijun, et al. "Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target." Clinical Cancer Research 16.3 (2010): 814-824.
27. Jaganathan, Soumya, Peibin Yue, and James Turkson. "Enhanced sensitivity of pancreatic cancer cells to concurrent inhibition of aberrant signal transducer and activator of transcription 3 and epidermal growth factor receptor or Src."Journal of Pharmacology and Experimental Therapeutics 333.2 (2010): 373-381.
28. Soto, Carissa M., and Banahalli R. Ratna. "Virus hybrids as nanomaterials for biotechnology." Current opinion in biotechnology 21.4 (2010): 426-438.
29. Chaerkady R, Harsha H C, Nalli A, et al. A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma[J]. Journal of proteome research, 2008, 7(10): 4289-4298.
30. Chaerkady, Raghothama, et al. "18O Labeling for a quantitative proteomic analysis of glycoproteins in hepatocellular carcinoma." Clinical proteomics 4.3-4 (2008): 137-155.
31. Harris, Molly A., et al. "Cancer stem cells are enriched in the side population cells in a mouse model of glioma." Cancer research 68.24 (2008): 10051-10059.
32. Tanese, Keiji, Elizabeth A. Grimm, and SuhendanEkmekcioglu. "The role of melanoma tumor‐derived nitric oxide in the tumor inflammatory microenvironment: Its impact on the chemokine expression profile, including suppression of CXCL10." International journal of cancer 131.4 (2012): 891-901.
33. Gass, Justin T., and M. Foster Olive. "Transcriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEP." European journal of pharmacology 584.2 (2008): 253-262.
34. Davis, Cristina E., et al. "Effects of phospholemman expression on swelling-activated ion currents and volume regulation in embryonic kidney cells."Neurochemical research 29.1 (2004): 177-187.
35. Wu Y, Lu J, Antony S, et al. Activation of TLR4 is required for the synergistic induction of dual oxidase 2 and dual oxidase A2 by IFN-γ and lipopolysaccharide in human pancreatic cancer cell lines[J]. The Journal of Immunology, 2013, 190(4): 1859-1872.
36. Murthy S R K, Dupart E, Al-Sweel N, et al. Carboxypeptidase E promotes cancer cell survival, but inhibits migration and invasion[J]. Cancer letters, 2013, 341(2): 204-213.
37. Ekmekcioglu, Suhendan, et al. "Zyflamend mediates therapeutic induction of autophagy to apoptosis in melanoma cells." Nutrition and cancer 63.6 (2011): 940-949.
38. Kim, Dae Young, et al. "Mutational approaches to improve the biophysical properties of human single-domain antibodies." BiochimicaetBiophysicaActa (BBA)-Proteins and Proteomics (2014).
39. Sokolowska, Izabela, et al. "Identification of a potential tumor differentiation factor receptor candidate in prostate cancer cells." FEBS Journal 279.14 (2012): 2579-2594.
40. Du, Zhi-Qiang, et al. "Novel microRNA families expanded in the human genome." BMC genomics 14.1 (2013): 98.
41. Horgan C P, Hanscom S R, Kelly E E, et al. Tumor susceptibility gene 101 (TSG101) is a novel binding-partner for the class II Rab11-FIPs[J]. PloS one, 2012, 7(2): e32030.
42. Jaganathan S. STUDY OF THE EGFR, SRC, AND STAT3 PATHWAY IN PANCREATIC CANCER[D]. University of Central Florida Orlando, Florida, 2010.
43. Wanczyk H, Barker T, Rood D, et al.Cloning and characterization of a hybridoma secreting a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-specific monoclonal antibody and recombinant F (ab)[J]. Toxins, 2013, 5(3): 568-589.
44. Thomas, Nikhil, et al. "Construction and Characterization of a Single-Chain Variable Fragment Antibody Library against Fusobacteriumnucleatum." (2012).
45. Sang, Nianli, et al. "Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis." Cell Cycle 11.12 (2012): 2348-2358.
46. Postovit, Lynne-Marie, et al. "Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells."Proceedings of the National Academy of Sciences 105.11 (2008): 4329-4334.

Book Chapters

1. Jim De Yoreo (2013). Biomimetic crystallization techniques in vitro. InResearch Methods in Biomineralization Science(pp308). Amsterdam, Netherlands: Elsevier.
2. American Association for Cancer Research, William H. Donner Foundation (2008). Cancer Research (pp142). Baltimore, USA: Waverly Press.
3. Genetic Engineering & Biotechnology News (2009): GEN., Volume 29, Issues 1-8 (pp48, pp56). NY, USA: GEN Pub. Inc.
4. Liu, Hong-Yan, et al. "Imbalanced response of ATP-binding cassette transporter A1 and CD36 expression to increased oxidized low-density lipoprotein loading contributes to the development of THP-1 derived foam cells." Journal of biochemistry 155.1 (2014): 35-42.
5. Schwab, Andrew J., and Allison D. Ebert. "Sensory Neurons Do Not Induce Motor Neuron Loss in a Human Stem Cell Model of Spinal Muscular Atrophy."PloS one 9.7 (2014): e103112.
6. Kim, Yong‐Gil, et al. "Role of Protein Phosphatase Magnesium‐Dependent 1A and Anti–Protein Phosphatase Magnesium‐Dependent 1A Autoantibodies in Ankylosing Spondylitis." Arthritis & Rheumatology 66.10 (2014): 2793-2803.
7. Amraoui, Fouad, et al. "SFlt-1 Elevates Blood Pressure by Augmenting Endothelin-1-Mediated Vasoconstriction in Mice." PloS one 9.3 (2014): e91897.
8. Liu, Wenlong, et al. "Anti-Inflammatory Effect of IL-37b in Children with Allergic Rhinitis." Mediators of inflammation 2014 (2014).
9. Hector, Andreas, et al. "The chemokine CCL18 characterises Pseudomonas infections in cystic fibrosis lung disease." European Respiratory Journal (2014): erj00700-2014.
10. Siddique, Imad, et al. "Gremlin Promotes Peritoneal Membrane Injury in an Experimental Mouse Model and Is Associated with Increased Solute Transport in Peritoneal Dialysis Patients." The American journal of pathology (2014).
11. Richens, Joanna L., et al. "Practical detection of a definitive biomarker panel for Alzheimer’s disease; comparisons between matched plasma and cerebrospinal fluid." Int J MolEpidemiol Genet 5.2 (2014): 53-70.
12. Edin, Nina Jeppesen, et al. "The roles of TGF-β3 and peroxynitrite in removal of hyper-radiosensitivity by priming irradiation." International journal of radiation biology 0 (2014): 1-23.
13. Aupperlee, Mark D., et al. "Epidermal Growth Factor Receptor (EGFR) Signaling Is a Key Mediator of Hormone-Induced Leukocyte Infiltration in the Pubertal Female Mammary Gland." Endocrinology 155.6 (2014): 2301-2313.
14. Tang, Sung-Chun, et al. "Functional role of soluble receptor for advanced glycation end products in stroke." Arteriosclerosis, thrombosis, and vascular biology 33.3 (2013): 585-594.
15. Peraramelli, S., et al. "Direct inhibition of factor VIIa by TFPI and TFPI constructs." Journal of Thrombosis and Haemostasis 11.4 (2013): 704-714.
16. Zhao, Yingxin, et al. "Quantitation of the Dynamic Profiles of the Innate Immune Response Using Multiplex Selected Reaction Monitoring–Mass Spectrometry."Molecular& Cellular Proteomics 12.6 (2013): 1513-1529.
17. Laprevotte, Emilie, et al. "Endogenous IL-8 acts as a CD16 co-activator for natural killer-mediated anti-CD20 B cell depletion in chronic lymphocytic leukemia." Leukemia research 37.4 (2013): 440-446.
18. Li, Yanzhang, et al. "Thrombospondin 1 activates the macrophage Toll-like receptor 4 pathway." Cellular & molecular immunology (2013).
19. Sreenivasan, Sandhya, and Christopher D. Viljoen. "OCT1 identity crisis." Gene516.1 (2013): 190-191.
20. Huang, Sheng-He, et al. "Circulating brain microvascular endothelial cells (cBMECs) as potential biomarkers of the blood–brain barrier disorders caused by microbial and non-microbial factors." PloS one 8.4 (2013): e62164.
21. Görgens, Sven W., et al. "Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells." Archives of physiology and biochemistry 119.2 (2013): 75-80.
22. Svensson, Mattias ND, et al. "Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis." PloS one 8.1 (2013): e54884.
23. Tomiyama, Takashi, et al. "Antigen-specific suppression and immunological synapse formation by regulatory T cells require the mst1 kinase." PloS one 8.9 (2013): e73874.
24. Pillai, Deepu R., et al. "Neurovascular protection by targeting early blood–brain barrier disruption with neurotrophic factors after ischemia–reperfusion in rats*."Journal of Cerebral Blood Flow & Metabolism 33.4 (2013): 557-566.
25. Kostikov, Alexey P., et al. "Oxalic Acid Supported Si–18F-Radiofluorination: One-Step Radiosynthesis of N-Succinimidyl 3-(Di-tert-butyl [18F] fluorosilyl) benzoate ([18F] SiFB) for Protein Labeling." Bioconjugate chemistry 23.1 (2012): 106-114.
26. Dilek, Nahzli, et al. "Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5." The Journal of Immunology 188.9 (2012): 4209-4216.
27. Abdiche, Yasmina N., et al. "Label-free epitope binning assays of monoclonal antibodies enable the identification of antigen heterogeneity." Journal of immunological methods 382.1 (2012): 101-116.
28. Zhou, Qing, et al. "Aptamer-Containing Surfaces for Selective Capture of CD4 Expressing Cells." Langmuir 28.34 (2012): 12544-12549.
29. Hun, Xu, et al. "Indole-3-acetic acid biosensor based on G-rich DNA labeled AuNPs as chemiluminescence probe coupling the DNA signal amplification."SpectrochimicaActa Part A: Molecular and Biomolecular Spectroscopy 95 (2012): 114-119.
30. Pucci, Mariangela, et al. "Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor." Journal of Biological Chemistry 287.19 (2012): 15466-15478.
31. Munisso, Maria Chiara, et al. "Cilomilast enhances osteoblast differentiation of mesenchymal stem cells and bone formation induced by bone morphogenetic protein 2." Biochimie 94.11 (2012): 2360-2365.
32. Dynon, Kemperly, et al. "HtrA3 as an early marker for preeclampsia: specific monoclonal antibodies and sensitive high-throughput assays for serum screening." PloS one 7.9 (2012): e45956.
33. Hassan, Ali H. Injectable liposomes for controlled release of rhBMP-2 for the repair of alveolar defects in rabbits. Diss. Department of Orthodontics, Faculty of Dentistry, King Abdulaziz University.
34. Mauk, Marcia R., Ann Smith, and A. Grant Mauk. "An alternative view of the proposed alternative activities of hemopexin." Protein Science 20.5 (2011): 791-805.
35. Furuya, Mitsuko, et al. "Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis." Gynecologic oncology 122.3 (2011): 648-655.
36. Emdad, Luni, et al. "Is there a common upstream link for autophagic and apoptotic cell death in human high-grade gliomas?." Neuro-oncology 13.7 (2011): 725-735.
37. Mellor, Kimberley M., et al. "Cardiomyocyteglycophagy is regulated by insulin and exposure to high extracellular glucose." American Journal of Physiology-Heart and Circulatory Physiology 306.8 (2014): H1240-H1245.
38. Wu, Chih-Ching, et al. "Salivary auto-antibodies as noninvasive diagnostic markers of oral cavity squamous cell carcinoma." Cancer Epidemiology Biomarkers & Prevention (2014): cebp-1269.
39. Gealekman, Olga, et al. "Control of Adipose Tissue Expandability in Response to High Fat Diet by the Insulin-like Growth Factor Binding Protein-4." Journal of Biological Chemistry (2014): jbc-M113.
40. Chu, Uyen B., et al. "Noncompetitive Inhibition of Indolethylamine N-Methyltransferase by N, N Dimethyltryptamine (DMT) and N, N-Dimethylaminopropyltryptamine." Biochemistry (2014).
41. Doudevski, Ivo, et al. "Clusterin and complement activation in exfoliation glaucoma." Investigative ophthalmology & visual science 55.4 (2014): 2491-2499.
42. Rousse, Monika, et al. "a new generation of topical chronic wound treatments containing specific MMP inhibitors." (2014).
43. Ray, Partha, Bruce A. Sullenger, and Rebekah R. White. "Further Characterization of the Target of a Potential Aptamer Biomarker for Pancreatic Cancer: Cyclophilin B and Its Posttranslational Modifications." Nucleic acid therapeutics 23.6 (2013): 435-442.
44. Ma, Yuanyuan, et al. "SHBG Is an Important Factor in Stemness Induction of Cells by DHT In Vitro and Associated with Poor Clinical Features of Prostate Carcinomas." PloS one 8.7 (2013): e70558.
45. Yokota, Naho, et al. "Contributions of thrombin targets to tissue factor‐dependent metastasis in hyperthrombotic mice." Journal of Thrombosis and Haemostasis 12.1 (2014): 71-81.
46. Herrera, Victoria L., et al. "DEspR Roles in Tumor Vasculo-Angiogenesis, Invasiveness, CSC-Survival and Anoikis Resistance: A ‘Common Receptor Coordinator’Paradigm." PloS one 9.1 (2014): e85821.
47. Frese‐Schaper, Manuela, et al. "Low dose irinotecan improves advanced lupus nephritis in mice potentially by changing DNA relaxation and anti‐dsDNA binding." Arthritis & Rheumatology (2014).
48. Glogowska, Aleksandra, et al. "C1q‐tumour necrosis factor‐related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells." The Journal of pathology 231.4 (2013): 466-479.
49. Madke, Gabriel Ribeiro, et al. "Effect of positive end-expiratory pressure after porcine unilateral left lung transplant." Experimental and clinical transplantation: official journal of the Middle East Society for Organ Transplantation 11.1 (2013): 50-55.
50. Chandrasekhar, Anjana, et al. "MASP-2." UCSD Molecule Pages 2.2 (2013).
51. Schibel, Anna EP, and Eric N. Ervin. "Antigen Detection via the Rate of Ion Current Rectification Change of the Antibody-Modified Glass Nanopore Membrane." Langmuir (2014).
52. Ndong, Jean de la Croix, et al. "Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1OSX‐/‐mice."Journal of Bone and Mineral Research (2014).
53. Paige, Mikell, et al. "Role of Leukotriene A4 Hydrolase Aminopeptidase in the Pathogenesis of Emphysema." The Journal of Immunology 192.11 (2014): 5059-5068.
54. Khosravi, Roozbeh, et al. "Collagen advanced glycation inhibits its discoidin domain receptor 2 (DDR2)-mediated induction of lysyl oxidase in osteoblasts."Bone 58 (2014): 33-41.
55. Pang, Liping, et al. "Mimicking filtration and transport of rotavirus and adenovirus in sand media using DNA-labeled, protein-coated silica nanoparticles." Water research 62 (2014): 167-179.
56. Chowdhury, Subrata, et al. "IGF-I Stimulates CCN5/WISP2 Gene Expression in Pancreatic β-Cells, Which Promotes Cell Proliferation and Survival AgainstStreptozotocin." Endocrinology 155.5 (2014): 1629-1642.
57. Edin, Nina F. Jeppesen. "The role of interleukin-13 in the removal of hyper-radiosensitivity by priming irradiation." Journal of radiation research (2014): rru053.
58. Helsby M A, Leader P M, Fenn J R, et al. CiteAb: a searchable antibody database that ranks antibodies by the number of times they have been cited[J]. BMC cell biology, 2014, 15(1): 6.
59. Hor, YitTeng, et al. "A Role for RUNX3 in Inflammation-Induced Expression of IL23A in Gastric Epithelial Cells." Cell reports 8.1 (2014): 50-58.
60. Araujo, Luiz Felipe Lopes, et al. "Effect of the systemic administration of methylprednisolone on the lungs of brain-dead donor rats undergoing pulmonary transplantation." Clinics 69.2 (2014): 128-133.
61. Gelinas, Amy D., et al. "Crystal structure of interleukin-6 in complex with a modified nucleic acid ligand." Journal of Biological Chemistry 289.12 (2014): 8720-8734.
62. Stafford, Ryan L., et al. "In vitro Fab display: a cell-free system for IgG discovery." Protein Engineering Design and Selection 27.4 (2014): 97-109.
63. Nakazawa, Daigo, et al. "Enhanced Formation and Disordered Regulation of NETs in Myeloperoxidase-ANCA-Associated Microscopic Polyangiitis." Journal of the American Society of Nephrology: JASN (2014).
64. Wisniewska, Magdalena, et al. "Functional and Structural Properties of a Novel Protein and Virulence Factor (sHIP) in Streptococcus pyogenes." Journal of Biological Chemistry (2014): jbc-M114.
65. Shandilya, Jayasha, et al. "WT1 interacts with MAD2 and regulates mitotic checkpoint function." Nature communications 5 (2014).
66. Guan, Xiangying, et al. "Mechanism of Inhibition of the Human Sirtuin Enzyme SIRT3 by Nicotinamide: Computational and Experimental Studies." PloS one9.9 (2014): e107729.
67. Shaw, Alan, et al. "Spatial control of membrane receptor function using ligand nanocalipers." Nature methods 11.8 (2014): 841-846.
68. Sreenivasan, Sandhye. Impact of ImatinibMesylate on SLC22A1 Gene Expression in Chronic Myeloid Leukaemia Cell Line, K562. Diss. University of the Free State, 2013.
69. He, Kunyan, et al. "Blockade of Glioma Proliferation Through Allosteric Inhibition of JAK2." Science signaling 6.283 (2013): ra55.
70. Pilla, Eduardo Sperb, et al. "Effects of methylprednisolone on inflammatory activity and oxidative stress in the lungs of brain-dead rats." JornalBrasileiro de Pneumologia 39.2 (2013): 173-180.
71. Anand, Appakkudal R., et al. "N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton." Retrovirology 10.2 (2013).
72. Kim, Jiyoung, Jee-Hyun Yoon, and Yeon-Soo Kim. "HIV-1 Tat interacts with and regulates the localization and processing of amyloid precursor protein." PloS one 8.11 (2013): e77972.
73. Ezzat, Shereen, et al. "The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes." Cell metabolism 17.6 (2013): 929-940.
74. Anne, Sandrine L., et al. "WNT3 inhibits cerebellar granule neuron progenitor proliferation and medulloblastoma formation via MAPK activation." PloS one8.11 (2013): e81769.
75. Barletta, Bianca, et al. "Probiotic VSL# 3‐induced TGF‐β ameliorates food allergy inflammation in a mouse model of peanut sensitization through the induction of regulatory T cells in the gut mucosa." Molecular nutrition & food research 57.12 (2013): 2233-2244.
76. Joshi, Rucha V., et al. "Dual pH-and temperature-responsive microparticles for protein delivery to ischemic tissues." Actabiomaterialia 9.5 (2013): 6526-6534.
77. Roberson, Kevin J., et al. "Methods to Identify the NMR Resonances of the 13C-Dimethyl N-terminal Amine on Reductively Methylated Proteins." JoVE (Journal of Visualized Experiments) 82 (2013): e50875-e50875.
78. Strop, Pavel, et al. "Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair." Journal of molecular biology 420.3 (2012): 204-219.
79. Kato, Yoji, et al. "Myeloperoxidase catalyzes the conjugation of serotonin to thiols via free radicals and tryptamine-4, 5-dione." Chemical research in toxicology 25.11 (2012): 2322-2332.
80. Johnson, Nicholas, et al. "TRC40 can deliver short secretory proteins to the Sec61 translocon." Journal of cell science 125.15 (2012): 3612-3620.
81. Andersson, Sofia EM, et al. "Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis." PloS one 7.10 (2012): e47668.
82. Perera, Natascha C., et al. "NSP4, an elastase-related protease in human neutrophils with arginine specificity." Proceedings of the National Academy of Sciences 109.16 (2012): 6229-6234.
83. Davies, Douglas R., et al. "Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets." Proceedings of the National Academy of Sciences 109.49 (2012): 19971-19976.
84. Li, Yanchun. "Functional Characterization of CXCR3 Receptor Isoforms in Breast Cancer." (2012).
85. Stiehl, D. P., et al. "Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG–EGFR/ErbB4 autocrine loop." Oncogene 31.18 (2011): 2283-2297.
86. Sun, Huifang, Chia-Hui Lin, and Michael E. Smith. "Growth hormone promotes hair cell regeneration in the zebrafish (Daniorerio) inner ear following acoustic trauma." PloS one 6.11 (2011): e28372.
87. Sustainable Chemistry Solutions, Inc. (2013). Enzyme Sources Guide (pp17, pp169). Burbank, California, USA:Sustainable Chemistry Solutions, Inc.
88. Yehuda Shoenfeld, Pier Luigi Meroni, M. Eric Gershwin (2013). Autoantibodies to Biologic Factors/ Structures. In Autoantibodies (pp320). Oxford and Boston, UK: Newnes.
89. Alan J. Barrett, Neil D. Rawlings, J. Fred Woessner (2012). Serine and Threonine Peptidases. In Handbook of Proteolytic Enzymes, Volume 1 ( pp3381). Waltham, Massachusetts, USA. Academic Press